Evidence map›Paper›PMID 39992999›Full record

ArticlePLOS global public health2025

Continued T12 transmission and shared antibiotic resistance during 2018-2023 Vibrio cholerae outbreaks in Cameroon.

Sen Claudine Henriette Ngomtcho, Blaise Mboringong Akenji, Roland Ndip, Andrew S Azman, Yanick Carolle Tayimetha, Etienne Guenou, Sylvain Engamba, Marie Claire Assoumou Okomo, Justin Lessler, Shirlee Wohl

Abstract read
In one paragraph

Article in PLOS global public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Sen Claudine Henriette NgomtchoMolecular Biology Unit, National Public Health Laboratory, Yaoundé, Cameroon.ORCID https://orcid.org/0000-0001-5045-3065
Blaise Mboringong AkenjiMolecular Biology Unit, National Public Health Laboratory, Yaoundé, Cameroon.
Roland NdipDepartment of Microbiology and Parasitology, Faculty of Science, University of Buea, Buea, Cameroon.
Andrew S AzmanDepartment of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America.
Yanick Carolle TayimethaBacteriology Unit, National Public Health Laboratory, Yaoundé, Cameroon.ORCID https://orcid.org/0000-0003-1482-3828
Etienne GuenouBacteriology Unit, National Public Health Laboratory, Yaoundé, Cameroon.ORCID https://orcid.org/0000-0002-8027-7311
Sylvain EngambaBacteriology Unit, National Public Health Laboratory, Yaoundé, Cameroon.
Marie Claire Assoumou OkomoMolecular Biology Unit, National Public Health Laboratory, Yaoundé, Cameroon.
Justin LesslerDepartment of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America.ORCID https://orcid.org/0000-0002-9741-8109
Shirlee WohlDepartment of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America.ORCID https://orcid.org/0000-0002-0311-3348

Funding

Gates Foundation INV-025321
6 · The paper itself

Abstract

Seventh pandemic Vibrio cholerae was first identified in Cameroon in 1971, causing several sporadic disease clusters with few cases. More recent years have seen larger cholera outbreaks, but the mechanism behind these periodic outbreaks is poorly understood, and it is unclear the degree to which antibiotic resistant strains contribute to disease burden and spread. We used whole genome sequencing to characterize 13 V. cholerae isolates from the 2018-2019, 2020, and 2021-2023 cholera epidemics in Cameroon. All these isolates belonged to the T12 lineage, and most showed the same antimicrobial resistance (AMR) pattern regardless of year. This suggests that cholera outbreaks in Cameroon are, at least in part, a continuation of the outbreaks previously reported in 2018 and as far back as 2012. This finding has important implications for cholera management since it suggests the ongoing presence of pathogenic cholera even in years with few reported cases. Similarly, the AMR results suggest the need for new treatment approaches, as resistance to many common antibiotics was found even within our limited sample set. As such, whole genome sequencing should be implemented in low-income countries such as Cameroon to improve disease surveillance and to detect and predict pathogen antibiotic resistance profiles.

Identifiers

PMID39992999
PMCPMC11849833

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.